HERBALIFE LTD. Repayments of Convertible Debt
HERBALIFE LTD. (HLF) reported Repayments of Convertible Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-02-18
- HERBALIFE LTD. repayments of convertible debt for the quarter ending 2025-12-31 was $0.00.
- HERBALIFE LTD. repayments of convertible debt for the quarter ending 2025-09-30 was $0.00.
- HERBALIFE LTD. repayments of convertible debt for the quarter ending 2025-06-30 was $0.00.
- HERBALIFE LTD. repayments of convertible debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- HERBALIFE LTD. repayments of convertible debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- HERBALIFE LTD. repayments of convertible debt for fiscal 2024 was $197.00M, a 206.38% increase from fiscal 2023.
- HERBALIFE LTD. repayments of convertible debt for fiscal 2023 was $64.30M, a 76.46% decline from fiscal 2022.
- HERBALIFE LTD. repayments of convertible debt for fiscal 2022 was $273.20M.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $0.00 derived: sum of 2 quarters · filed 2026-02-18 | $0.00 derived: sum of 3 quarters · filed 2026-02-18 | $0.00 10-K · filed 2026-02-18 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-18 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-18 | $0.00 derived: sum of 4 quarters · filed 2026-02-18 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-02-18 | $0.00 derived: sum of 3 quarters · filed 2026-02-18 | $0.00 derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $0.00 derived: sum of 2 quarters · filed 2026-02-18 | $0.00 derived: sum of 3 quarters · filed 2026-02-18 | $197.00M 10-K · filed 2026-02-18 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $197.00M 10-Q · filed 2025-11-05 | $197.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $197.00M 10-Q · filed 2025-08-06 | $197.00M derived: sum of 3 quarters · filed 2026-02-18 | $261.30M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $197.00M 10-Q · filed 2025-04-30 | $197.00M derived: sum of 2 quarters · filed 2026-02-18 | $261.30M derived: sum of 3 quarters · filed 2026-02-18 | $261.30M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $64.30M derived: sum of 2 quarters · filed 2026-02-18 | $64.30M derived: sum of 3 quarters · filed 2026-02-18 | $64.30M 10-K · filed 2026-02-18 |
| 2023-09-30 | $64.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $64.30M derived: sum of 2 quarters · filed 2024-10-30 | $64.30M 10-Q · filed 2024-10-30 | $337.50M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | $273.20M derived: sum of 3 quarters · filed 2025-02-19 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $273.20M derived: sum of 2 quarters · filed 2025-02-19 | ||
| 2022-12-31 | $273.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $273.20M 10-K · filed 2025-02-19 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-14 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-14 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $675.00M 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $675.00M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $0.00 derived: sum of 2 quarters · filed 2021-02-17 | $0.00 derived: sum of 3 quarters · filed 2021-02-17 | $582.50M 10-K · filed 2021-02-17 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $0.00 derived: sum of 2 quarters · filed 2019-10-29 | $582.50M 10-Q · filed 2019-10-29 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $582.50M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $582.50M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |